1. Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
   Tesfay M. Godefa et al, 2022, Cancers CrossRef
2. Expression of Sialyl Lewis a, Sialyl Lewis x, Lewis y, Gal-3, Gal-7, STMN1 and p16 in cervical dysplasia
   Theresa M Kolben et al, 2017, Future Oncology CrossRef
3. Inflammatory Biomarkers and Neurotransmitter Perturbations in Delirium
   José R. Maldonado, 2020, Delirium CrossRef
4. Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells
   Jingxin Zhang et al, 2018, Oncology Letters CrossRef
5. Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells
   Guanghui Cui et al, 2015, Medical Oncology CrossRef
6. MicroRNA‑490‑3p inhibits proliferation and stimulates apoptosis of ESCC cells via MAPK1 downregulation
   Baerxiaguli Zabihula et al, 2019, Oncology Letters CrossRef
7. Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells
   LILI QIAO et al, 2016, Molecular Medicine Reports CrossRef